Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-139508
Filing Date
2017-04-26
Accepted
2017-04-26 16:17:58
Documents
3
Period of Report
2017-06-12
Effectiveness Date
2017-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d356798ddef14a.htm DEF 14A 749557
2 GRAPHIC g356798dsp001.jpg GRAPHIC 305568
3 GRAPHIC g356798dsp002.jpg GRAPHIC 176320
  Complete submission text file 0001193125-17-139508.txt   1414567
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33221 | Film No.: 17784578
SIC: 2834 Pharmaceutical Preparations